Celltrion Healthcare, Foreigners Net Buy 30,000 Shares... Stock Price Up 2.1%
As of 12:33 PM on the 8th, Celltrion Healthcare is trading at 97,200 KRW, up 2.1% from the previous day. This marks a 12.5% increase compared to May 28. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have a net purchase of 30,000 shares of Celltrion Healthcare, while institutions have a net sale of 4,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 1,006,917 shares, while foreigners and institutions have net sold 535,986 shares and 470,376 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- 10 Million Apply for Second Round of High Oil Price Assistance in Two Days... Cumulative Payments Exceed 3 Trillion Won
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
